POLE and endometrial cancer: In addition to the traditional classification, based on staging and histology, last guidelines recommend to incorporate tumor biomarkers to allow endometrial cancer subgroup classification in four molecular subtypes: p53 abnormal, dMMR/MSI+, POLE-mutated, and “no specific molecular profile” (NSMP) [16, 17].